Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2026 06:40 ET | Source: Rocket Lab Corporation

Mission Success: Rocket Lab Completes 9th Electron Launch for Synspective

MAHIA, New Zealand, May 22, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today announced the successful deployment of the...
May 22, 2026 06:30 ET | Source: FTAI Aviation Ltd.

FTAI Aviation Prices Inaugural Asset-Backed Securitization

NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI; the “Company” or “FTAI”) today announced the successful pricing of its Strategic Capital vehicle’s inaugural asset-backed...
May 22, 2026 06:16 ET | Source: Yimutian Inc.

Yimutian’s WolaiCai AI Agent Goes Live Across All Platforms: 200 Million Daily Token Consumption, Agricultural AI Revenue Exceeds US$3,000 Per Day

Chinese agri-tech leader Yimutian (Nasdaq: YMT) launched its WolaiCai AI Agent , achieving 200M+ daily token consumption and $3,000+ daily AI revenue.
May 22, 2026 06:00 ET | Source: Lixiang Education Holding Co., Ltd.

Lixiang Education Regains Compliance with Nasdaq Minimum Bid Price Requirement

LISHUI, China, May 22, 2026 (GLOBE NEWSWIRE) -- Lixiang Education Holding Co., Ltd. (the “Company” or NASDAQ: LXEH), a prestigious private education service provider in China, today announced that...
May 22, 2026 05:00 ET | Source: BioNTech SE

BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting

BioNTech SE will present new clinical data and trial updates from its late-stage oncology pipeline and innovative combination programs at ASCO 2026.
May 22, 2026 05:00 ET | Source: BioNTech SE

BioNTech präsentiert auf der ASCO-Jahrestagung 2026 Fortschritte aus Pipelineprogrammen in der späten klinischen Entwicklung

BioNTech SE präsentiert neue klinische Daten und Studienupdates zu Programmen in der spätklinischen Entwicklung sowie zu innovativen Kombinationsprogrammen
May 21, 2026 23:27 ET | Source: NervGen Pharma Corp.

NervGen Announces Pricing of US$60.0 Million Public Offering of Securities

VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class...
May 21, 2026 23:20 ET | Source: Yimutian Inc.

Yimutian Inc. Announces Submission of Hearing Request to Nasdaq and Proactive Measures to Regain Full Compliance

BEIJING, May 21, 2026 (GLOBE NEWSWIRE) -- Yimutian Inc. (Nasdaq: YMT) (“Yimutian” or the “Company”), a leading agricultural digital service company in China, today announced that it has formally...
May 21, 2026 22:45 ET | Source: Medline Inc.

Medline Inc. announces pricing of upsized secondary offering of Class A common stock

NORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.’s Class...
May 21, 2026 22:30 ET | Source: All In FutureTech Alliance, Inc.

AIFA Provides Update on Nasdaq Notice and Filing of Annual Report, Clearing Key Pathways for Strategic Transformation

NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- All In FutureTech Alliance, Inc. (Nasdaq: AGAE) (the “Company” or “AIFA”) today provided an update regarding the previously received notice from the...